Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 19, 2016

Primary Completion Date

February 9, 2017

Study Completion Date

February 9, 2017

Conditions
Typhoid
Interventions
BIOLOGICAL

Vi-DT

Manufacturer: SK Chemicals Co., Ltd. Ingredient: Purified Vi-polysaccharide conjugated to diphtheria toxoid Dose: 0.5 mL/Vial

BIOLOGICAL

Typhim Vi®

Manufacturer: Sanofi Pasteur Ingredient: Purified Vi-polysaccharide Appearance: colourless liquid Dose: 0.5mL/vial

BIOLOGICAL

VAXIGRIP®

"Dose: Single injection, participants 6-35 months of age will receive 0.25 ml (half a dose), participants 36 months of age and older will receive 0.5ml (full dose)~\*Participants less than 9 years of age, who have not been vaccinated for flu before, will receive a second dose of flu-vaccine after the last follow-up visit of last participant in their age cohort."

All Listed Sponsors
collaborator

SK Chemicals Co., Ltd.

INDUSTRY

lead

International Vaccine Institute

OTHER

NCT02645032 - Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine | Biotech Hunter | Biotech Hunter